Product Information
PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $3.2920 per EA under NDC 43598062530. Its NADAC has been published 53 times since Aug 20, 2025.
FDA first approved this application on Jun 12, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5; 46 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598062530
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDE; TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA208175FDA Approved
6/12/2025
TE Code
AB
On Market Since
6/1/2025
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE has been published 53 times since Aug 20, 2025, and over the history we have for it it has declined 29.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2920 per EA |
|---|---|
| All-time high | $4.6508 (Sep 10, 2025) |
| All-time low | $3.1410 (Feb 18, 2026) |
| 52-week high | $4.6508 |
| 52-week low | $3.1410 |
| Median price | $3.3727 |
| Average price | $3.5793 |
| Largest weekly change | -14.2% (Sep 17, 2025) |
| Weeks tracked | 53 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Phentermine and Topiramate Extended-Release market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $3.2920 per EA (NDC 43598062530), effective Aug 19, 2026.
How has the price of PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE has declined 29.2%. It has been tracked across 53 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE?
Since Aug 20, 2025, the NADAC for PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE has ranged from a low of $3.1410 (Feb 18, 2026) to a high of $4.6508 (Sep 10, 2025), with a median of $3.3727 per EA.
Are there cheaper alternatives to PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE?
PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE (NDC 43598062530) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.